PHILADELPHIA, Sept. 30, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced that a member of its Board of Directors, Professor William M. Mitchell, M.D., Ph.D., will deliver an invited lecture on “Toll-Like Receptor (TLR) Agonists and the Induction of the Innate Immune Response” in Nuerenberg, Germany. The international symposia, sponsored by the German Association of Pharmaceutical Scientists, recognizes Dr. Erlich’s breakthrough research on malaria, sleeping sickness and syphilis treatments more than a century ago.
